Cargando…
Newer human inosine 5′-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents
Human inosine 5′-monophosphate dehydrogenase 2 (hIMPDH2), being an age-old target, has attracted attention recently for anticancer drug development. Mycophenolic acid (MPA), a well-known immunosuppressant drug, was used a lead structure to design and develop modestly potent and selective analogues....
Autores principales: | Shah, Chetan P., Kharkar, Prashant S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009919/ https://www.ncbi.nlm.nih.gov/pubmed/29792360 http://dx.doi.org/10.1080/14756366.2018.1474211 |
Ejemplares similares
-
Different Characteristics and Nucleotide Binding Properties of Inosine Monophosphate Dehydrogenase (IMPDH) Isoforms
por: Thomas, Elaine C., et al.
Publicado: (2012) -
Fragment-Based
Approach to Targeting Inosine-5′-monophosphate
Dehydrogenase (IMPDH) from Mycobacterium tuberculosis
por: Trapero, Ana, et al.
Publicado: (2018) -
Identification of a potent dual-function inhibitor for hIMPDH isoforms by computer-aided drug discovery approaches
por: Yazdani, Meysam, et al.
Publicado: (2022) -
Inosine monophosphate dehydrogenase : a major therapeutic target /
Publicado: (2003) -
Disease Progression in Patients with Autosomal Dominant Retinitis Pigmentosa due to a Mutation in Inosine Monophosphate Dehydrogenase 1 (IMPDH1)
por: Bennett, Lea D., et al.
Publicado: (2020)